Europe Therapeutic Dog Food Market

The Europe therapeutic dog food market is expected to grow from US$ 1,920.56 million in 2021 to US$ 2,854.83 million by 2028; it is estimated to grow at a CAGR of 5.8% from 2021 to 2028.

A therapeutic diet is formulated to meet a pet's specific needs and is designed to combat or prevent diseases. The diet should comprise an optimum combination of carbohydrates, minerals, proteins, fats, vitamins, and water. Proper nutrition helps prevent infection among dogs and maintain their build, simultaneously allowing them to perform daily activities. Dog food manufacturers have been introducing products suitable for every stage of a dog’s life. Several of these products provide hypoallergenic nutrition, whereas other formulations are produced for controlling health conditions such as kidney and heart-related diseases, gastrointestinal issues, dental care, weight control, liver disease, and orthopedic conditions. Diets formulated to treat kidney disease are low in phosphorus and have moderate levels of proteins. A few therapeutic diets for skin disease contain proteins broken down into small pieces that are less likely to stimulate the immune response in dogs after consumption. Therefore, a therapeutic diet plays an important role in maintaining a dog’s health.

The countries in Europe are highly affected due to the COVID-19 pandemic. Italy and Spain have registered the maximum number of deaths due to COVIID-19. However, the animal health industry in European countries is minimally affected. The rapid increase in pet care spending in developed markets, such as the UK, Germany, and France, has also been accompanied by a surge in demand from newer and dynamic markets. In many countries, millennials are increasingly seeing pets as an alternative to children, driving pet adoption. As the COVID-19 crisis unfolds, the increase in pet care spending will change. At present, the short-term effects of the pandemic have been mixed, and many veterinary practices have remained closed for weeks due to containment measures. Also, the closure of adoption centers in a few countries slowed the pet ownership for some time in 2021. However, the market has not witnessed a sharp decline in the growth as many countries in the region have seen a rise in pet adoption after a few months.

With the new advancements and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe therapeutic dog food market. Similar to humans, animals too suffer from chronic diseases. Arthritis, chronic kidney disease, cancer, hepatitis and other liver diseases, skin allergies, and diabetes are commonly detected chronic diseases in pets. Cancer is increasingly widespread in companion and farm animals. According to the veterinary cancer society, the disease is a leading cause of death in 47% of dogs, especially dogs of age >10 years. Further, as per the Pet Cancer Facts and Figures, one in four dogs develop cancer in their lifetime. The Arthritis Foundation says ~20% of all adult dogs suffer from arthritis. Such growth in prevalence of chronic medical conditions has become a major concern among dog owners, which underlines the demand for proper care and diet. Thus, with the elevating prevalence of chronic medical conditions in dogs, pet food companies are focusing on producing advanced therapeutic and functional food products to help dog owners maintain the overall health of their pets.

 

Europe Therapeutic Dog Food Market Revenue and Forecast to 2028 (US$ Million)

Europe Therapeutic Dog Food Market Segmentation

• Europe Therapeutic Dog Food Market – By Product Type

  • Dry Food
  • Wet/ Canned Food
  • Snacks/ Treats
  • Others

• Europe Therapeutic Dog Food Market – By Application

  • Weight Management
  • Digestive Care
  • Allergy and Immune System Health
  • Others

• Europe Therapeutic Dog Food Market – By Country

  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe

Europe Therapeutic Dog Food Strategic Insights

Strategic insights for the Europe Therapeutic Dog Food provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Europe Therapeutic Dog Food Report Scope

Europe Therapeutic Dog Food Regional Insights

The geographic scope of the Europe Therapeutic Dog Food refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.